Abstract

Muscarinic receptor subtypes in human and guinea pig lung membranes were characterised using selective muscarinic antagonists. Competition experiments were carried out against [ 3H](−)-quinuclidinyl benzilate binding at 25°C in Tris-HCl buffer; non-specific binding was determined in the presence of 1 μM atropine. Of all the antagonists examined, only the M 1-selective antagonist pirenzepine exhibited a heterogeneous binding profile (n H < 1.0), best described by two-binding sites of high and low affinity. Binding of [ 3H]pirenzepine confirmed the presence of a high proportion of high affinity (M 1) receptors (60% of total) in human peripheral lung. The high potency of M 3-selective antagonists 4-diphenylacetoxy-N-methyl-piperidine methiodide (4-DAMP) and hexahydrosiladifenidol suggested the presence of M 3 receptors, but the low potency of AF-DX 116 and methoctramine indicated that there was no significant population of M 2 receptors present. The existence of muscarinic receptor subtypes in lung may have important clinical implication but their cellular localisation remains to be determined.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.